Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The combination treatment showed a higher response rate but no significant survival benefits.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Both drugs lower DHT levels, with GI198745 being more effective.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

CS12192 effectively treats alopecia areata with better safety than current options.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Tea polyphenol–zinc helps protect the liver and intestines from oxidative stress.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Applying a specific inhibitor lightens skin and hair color.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

The diphosphonate was the most effective at preventing calcification in rats.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

New hybrid compound found to effectively prevent hair loss.

Targeted cancer therapies often cause serious skin problems that need careful management.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.